SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: Emily Dickinson (HR-NI023)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 11judgment calls in the dossier
- 3protocol deviations
- 3orders and referrals without results in the record
- 6evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check ARB titration and SGLT2 inhibitor use without diabetes, the sick-day plan, home and video vital signs, and the recorded deviation. |
| provenance review | not_started | | | Four Emily Dickinson Museum pages and two PubMed abstracts logged. Bright's disease on the death certificate is D; hypertensive heart failure, iritis, anxiety, and epilepsy are R. Family history is left empty so that no health facts are attributed to her relatives. |
| safe messaging review | not_started | | | Mood and anxiety screens are below the thresholds for a safety assessment; her withdrawal is not labeled a disorder; her death is recorded without graphic detail. |
Judgment calls (dossier editorial resolutions)
- Index age. The episode presents her at 54, in the period of ill health that the museum dates from late 1883 to her death, when her letters mention severe headache and nausea. The synthetic date of birth is December 10, 1971, so the whole-year shift is 141 years. The index home visit is January 12, 2026 (true frame January 12, 1885). The chronic-care visits follow on February 2, March 2, June 1, and September 28, 2026; the sick visit is April 20, 2026; the preventive visit is October 19, 2026 (true frame February 2, March 2, April 20, June 1, September 28, and October 19, 1885). She died in May 1886, so all fall within her lifetime. The visit type is `preventive_adult` because she is under 65. The visits are set at home, by video, or on two combined clinic trips, which does not conflict with her documented life at the Homestead.
- Bright's disease and the kidney focus. That her physician entered Bright's disease on her death certificate is documented (D). What that broad nineteenth-century label meant in her case is retrospective: the museum reports the conclusion that she died of heart failure caused by severe hypertension and notes the absence of documented signs of nephritis (R, possible). No blood pressure or kidney test from her lifetime exists. The stage G3a A2 chronic kidney disease and the hypertension are synthetic; both problems are placed both_with_link to these claims, and the record does not claim that she had chronic kidney disease. Heart failure is not added to the synthetic episode.
- Eyes. Her eye treatment in Boston and Cambridgeport in 1864 and 1865 is documented (D). The diagnosis is not recorded; iritis, exotropia, a psychiatric cause, and hysterical hyperaesthesia of the retina are retrospective proposals (R, disputed), so the past medical history entry is graded R and no eye diagnosis is coded. The modern episode adds only a yearly hypertensive eye examination and a negative eye review.
- Withdrawal, anxiety, and mood. Her withdrawal from social life is documented (D). Whether it was a choice or had a medical cause such as an anxiety condition is disputed (R, sensitive), and agoraphobia and social anxiety are not used as labels. The synthetic PHQ-9 (6, then 3) and GAD-7 (5, then 3) stay below the thresholds for a diagnosis, so no anxiety or depressive disorder is coded, no F code is used, and no safety assessment is required. The care plan respects her wish to stay at home and does not treat it as a disorder. The epilepsy hypothesis (R, disputed) is recorded only as a rejected interpretation.
- Home-centered care. The index visit, the sick visit, and the three-month review are home visits; the four-week and six-month reviews are video visits with vital signs from her own validated upper-arm cuff (checked against the clinic device at the first clinic trip), scale, thermometer, and pulse oximeter, the respiratory rate counted on video, and blood drawn at home by a mobile phlebotomy service; the height is the measured clinic value. Cardiac auscultation is recorded as deferred at the two video visits. The clinic is used only twice, each time for several tasks on one quiet early appointment. This echoes the documented difficulty her physician had in examining her (D) without attributing any statement to him.
- Family and correspondents. The family history is left empty, and the social history and advance care planning name no one, so that no health fact or statement is attributed to her relatives or correspondents. The deaths and illnesses of family members mentioned on the museum pages are not used; the October 1883 bereavement is recorded only as “a death in her family.” Quotations and the epithet her sister used are not used.
- Not used. The 1996 and 1999 New England Quarterly articles by Hirschhorn and Longsworth, Wand and Sewall's 1979 article on her eyes (no abstract available), Leyda's chronology, Gordon's biography, and the Poetry Foundation page (HTTP 403) were not read and are not cited. A 2008 article proposing post-traumatic stress reactions was found but not used. Her early consumptive symptoms are recorded without a tuberculosis diagnosis.
- Sick and preventive visits. The sick visit is a viral gastroenteritis with volume depletion and a prerenal creatinine rise (1.32 to 1.66 mg/dL, potassium 5.3 mmol/L) while she was taking losartan, dapagliflozin, and amlodipine, chosen to teach sick-day rules in chronic kidney disease. It does not echo any documented illness. The preventive visit adds negative PHQ-2, GAD-7, and AUDIT-C screens, cervical HPV testing (result pending), an ordered mammogram and home stool test (no results invented), HepB-CpG dose 2, influenza and zoster vaccines, and advance care planning that names no one.
- Focused visits. The four chronic-care follow-ups (three weeks, eight weeks, about five months, and about eight and a half months after intake) are documented as focused visits on the CMID chronic kidney disease and hypertension monographs with KDIGO 2024 and 2021. Synthetic findings introduced: an earlier eGFR of 58 and urine albumin-creatinine ratio of 190 mg/g fourteen months before intake (prose only, to establish chronicity); headaches and nausea that eased as blood pressure fell; her home cuff agreeing within 4 mmHg of the clinic device. One protocol deviation is recorded as `deferred`, with its outcome and corrective action, and no result was invented: the metabolic panel planned two to three days after the sick visit was not drawn (she declined the home draw, and the medicines were restarted without a recheck; no harm, creatinine back to 1.30 mg/dL six weeks later). Cardiac auscultation at the two video visits is recorded as deferred because it could not be done by video.
- Consultation. The nephrology referral and consultation (Samuel Adeyemi, MD, a fictional consultant, on the day of the first clinic trip) are S. The consultant confirms chronicity and A2 albuminuria on two samples, judges hypertensive kidney disease the probable cause with no need for biopsy or serology, and recommends what the record then shows: losartan raised to 100 mg, dapagliflozin 10 mg, potassium and creatinine in 2 to 4 weeks, a systolic target below 120 with amlodipine if needed, the urine albumin-creatinine ratio at about three months, vitamin D repletion with bone-mineral recheck at 6 to 12 months, NSAID avoidance, sick-day rules, and hepatitis B vaccination. Nephrology video review in about a year is planned beyond the end of the record.
- Dickinson died in 1886, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-03-02 Progress note 03 (C-CDA) | Cardiac auscultation | Every visit | Not possible at a video visit; no new cardiac symptoms. It was done three weeks after intake at the clinic visit and will be done at the home visit in June |
2026-06-01 Progress note 05 (C-CDA) | Metabolic panel two to three days after the prerenal creatinine rise | Within days after acute kidney injury or a sick-day pause | Not drawn, a deviation from the plan: she felt better on the second day and declined the home draw, and the medicines were restarted after a nurse call without a recheck. No harm, judging by today's creatinine of 1.30 mg/dL and potassium of 4.7 mmol/L. Corrective action: after any kidney injury, the recheck is booked as a firm home draw before the clinician leaves, and the nurse confirms it was done before advising a restart |
2026-09-28 Progress note 06 (C-CDA) | Cardiac auscultation | Every visit | Not possible at a video visit; no cardiac symptoms. Done at the June home visit and planned at next month's preventive visit |
Orders and referrals without results in the record
| Visit | Type | Item | Status | Detail |
|---|
2026-10-19 Progress note 07 (C-CDA) | Prevention | Breast cancer screening | Ordered | No mammogram for four years because of the travel involved. Biennial screening from 40 to 74 discussed; a screening mammogram is booked at the imaging suite downstairs straight after this visit, so it needs no extra trip |
2026-10-19 Progress note 07 (C-CDA) | Prevention | Colorectal cancer screening | Ordered | No prior screening. Options discussed; she chose a yearly fecal immunochemical test she can do at home, and a kit was given today. A positive test needs colonoscopy |
2026-10-19 Progress note 07 (C-CDA) | Prevention | Eye examination | Referred | Dilated eye examination for hypertension, which the CMID advises yearly; she had eye treatment for light sensitivity long ago and none recently. Booked with the optometrist in this building on the day of her next clinic trip |
Evidence to check
Retrospective claims (R)
| Claim | Statement | Certainty |
|---|
| CLM-0006 | No record of the eye diagnosis survives. Her main symptoms were sensitivity to light, aching eyes, and a restricted ability to do close work; iritis is considered the most likely explanation, and exotropia, a psychiatric cause, and hysterical hyperaesthesia of the retina have also been proposed. | disputed |
| CLM-0008 | Scholars disagree whether her withdrawal was a deliberate artistic choice or had a medical origin, such as an anxiety condition. | disputed |
| CLM-0009 | A 2013 review by Hirschhorn and Longsworth rejects a proposed diagnosis of epilepsy on scientific, clinical, and biographical grounds. | disputed |
| CLM-0014 | Researchers have concluded that she died of heart failure caused by severe hypertension; no documentary evidence records the yellow pallor and odor associated with nephritis. | possible |
Sensitive claims
| Claim | Grade | Statement |
|---|
| CLM-0008 | R | Scholars disagree whether her withdrawal was a deliberate artistic choice or had a medical origin, such as an anxiety condition. |
| CLM-0010 | D | Her death came after two and a half years of ill health that followed a death in her family in October 1883 and a consequent nervous prostration; she later had two blackouts and was confined to bed for the seven months before her death. |
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
| Date | Result | Value | Flag |
|---|
| 2026-01-12 | Creatinine | 1.2 mg/dL (high) | High |
| 2026-01-12 | eGFR | 54 mL/min/1.73 m² (low) | Low |
| 2026-01-12 | Intact PTH | 74 pg/mL (high) | High |
| 2026-01-12 | 25-hydroxyvitamin D | 21 ng/mL (low) | Low |
| 2026-01-12 | Total cholesterol | 214 mg/dL (high) | High |
| 2026-01-12 | LDL cholesterol | 134 mg/dL (high) | High |
| 2026-01-12 | Urine albumin-creatinine ratio | 240 mg/g (high) | High |
| 2026-02-02 | BUN | 22 mg/dL (high) | High |
| 2026-02-02 | Creatinine | 1.26 mg/dL (high) | High |
| 2026-02-02 | eGFR | 51 mL/min/1.73 m² (low) | Low |
| 2026-02-02 | Urine albumin-creatinine ratio | 262 mg/g (high) | High |
| 2026-03-02 | BUN | 23 mg/dL (high) | High |
| 2026-03-02 | Creatinine | 1.32 mg/dL (high) | High |
| 2026-03-02 | eGFR | 48 mL/min/1.73 m² (low) | Low |
| 2026-06-01 | BUN | 22 mg/dL (high) | High |
| 2026-06-01 | Creatinine | 1.3 mg/dL (high) | High |
| 2026-06-01 | eGFR | 49 mL/min/1.73 m² (low) | Low |
| 2026-06-01 | Urine albumin-creatinine ratio | 118 mg/g (high) | High |
| 2026-09-28 | Creatinine | 1.28 mg/dL (high) | High |
| 2026-09-28 | eGFR | 50 mL/min/1.73 m² (low) | Low |
| 2026-09-28 | Urine albumin-creatinine ratio | 96 mg/g (high) | High |
| 2026-04-20 | Potassium | 5.3 mmol/L (high) | High |
| 2026-04-20 | Bicarbonate (total CO2) | 20 mmol/L (low) | Low |
| 2026-04-20 | BUN | 34 mg/dL (high) | High |
| 2026-04-20 | Creatinine | 1.66 mg/dL (high) | High |
| 2026-04-20 | eGFR | 36 mL/min/1.73 m² (low) | Low |